Payment overview · 2025
General Payments
$66.33
3 reported records · 2 companies
Healthcare provider profile · identity verified
Paul Vellozo, MD
Allopathic & Osteopathic Physicians|Internal Medicine · WALNUT RIDGE, AR · NPI 1386744274
Verified facts
What the public records show
CMS Open Payments records show Paul Vellozo, MD received $66.33 in general payments during 2025 across 3 reported records.
ABBVIE INC. accounted for 64.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $42.89 | 64.7% | 2 | 2025 |
| Viatris Specialty LLC | Unresolved — no canonical attribution shown | $23.44 | 35.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $66.33 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $42.89 | 2 | 2025 |
Source payment records
|
|||||
| YUPELRI Normalized: yupelri |
Drug | Viatris Specialty LLC | $23.44 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 652 | 169 |
| Omeprazole | Omeprazole | 460 | 102 |
| Levothyroxine Sodium | Levothyroxine Sodium | 432 | 82 |
| Gabapentin | Gabapentin | 418 | 76 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 371 | 80 |
| Potassium Chloride | Potassium Chloride | 321 | 65 |
| Lisinopril | Lisinopril | 311 | 75 |
| Amlodipine Besylate | Amlodipine Besylate | 307 | 78 |
| Ozempic | Semaglutide | 285 | 49 |
| Losartan Potassium | Losartan Potassium | 239 | 56 |
| Metformin Hcl | Metformin Hcl | 224 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 213 | 52 |
| Furosemide | Furosemide | 194 | 56 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 187 | 49 |
| Tamsulosin Hcl | Tamsulosin Hcl | 164 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 161 | 53 |
| Tramadol Hcl | Tramadol Hcl | 161 | 28 |
| Eliquis | Apixaban | 153 | 30 |
| Sertraline Hcl | Sertraline Hcl | 151 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 144 | 29 |
| Chlorthalidone | Chlorthalidone | 142 | 30 |
| Buspirone Hcl | Buspirone Hcl | 136 | 33 |
| Jardiance | Empagliflozin | 133 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 123 | 25 |
| Ropinirole Hcl | Ropinirole Hcl | 119 | 21 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 117 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 114 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 112 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 106 | 21 |
| Carvedilol | Carvedilol | 104 | 29 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 104 | 18 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 95 | 26 |
| Metoprolol Succinate | Metoprolol Succinate | 91 | 24 |
| Topiramate | Topiramate | 88 | 19 |
| Pregabalin | Pregabalin | 87 | 15 |
| Alprazolam | Alprazolam | 84 | 13 |
| Warfarin Sodium | Warfarin Sodium | 79 | 12 |
| Cefdinir | Cefdinir | 77 | 61 |
| Oxycodone Hcl | Oxycodone Hcl | 74 | 17 |
| Rexulti | Brexpiprazole | 73 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 71 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 70 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 70 | 18 |
| Promethazine Hcl | Promethazine Hcl | 66 | 17 |
| Glipizide Er | Glipizide | 65 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 65 | 24 |
| Fentanyl | Fentanyl | 61 | suppressed |
| Spironolactone | Spironolactone | 61 | 14 |
| Ezetimibe | Ezetimibe | 60 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 59 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 59 | 12 |
| Doxepin Hcl | Doxepin Hcl | 58 | 11 |
| Donepezil Hcl | Donepezil Hcl | 56 | 16 |
| Famotidine | Famotidine | 56 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 55 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 55 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 54 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 53 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 52 | suppressed |
| Ondansetron Odt | Ondansetron | 51 | 13 |
| Morphine Sulfate Er | Morphine Sulfate | 50 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 49 | 11 |
| Celecoxib | Celecoxib | 47 | 12 |
| Metformin Hcl Er | Metformin Hcl | 47 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | suppressed |
| Allopurinol | Allopurinol | 44 | 16 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 43 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 43 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 43 | suppressed |
| Mirtazapine | Mirtazapine | 42 | 11 |
| Prednisone | Prednisone | 42 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 40 | suppressed |
| Finasteride | Finasteride | 39 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 38 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 37 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 35 | 11 |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 35 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 34 | suppressed |
| Verapamil Er | Verapamil Hcl | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Clonazepam | Clonazepam | 33 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 33 | 15 |
| Alendronate Sodium | Alendronate Sodium | 31 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 26 |
| Fluconazole | Fluconazole | 31 | 16 |
| Vascepa | Icosapent Ethyl | 31 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 30 | suppressed |
| Atenolol | Atenolol | 30 | suppressed |
| Glipizide | Glipizide | 30 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | suppressed |
| Primidone | Primidone | 28 | suppressed |
| Estradiol | Estradiol | 27 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Methadone Hcl | Methadone Hcl | 27 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 26 | suppressed |
| Simvastatin | Simvastatin | 26 | suppressed |
| Sotalol | Sotalol Hcl | 26 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 25 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Baclofen | Baclofen | 24 | suppressed |
| Ranolazine Er | Ranolazine | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Bupropion Xl | Bupropion Hcl | 23 | suppressed |
| Nitroglycerin | Nitroglycerin | 23 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Phenytoin | Phenytoin | 21 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 20 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Victoza 3-Pak | Liraglutide | 19 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 18 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Nifedipine Er | Nifedipine | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Insulin Lispro | Insulin Lispro | 16 | suppressed |
| Movantik | Naloxegol Oxalate | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Olanzapine | Olanzapine | 14 | suppressed |
| Cholestyramine Light | Cholestyramine | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | 12 |
| Novolog | Insulin Aspart | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | 11 |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 12 | suppressed |
| Indapamide | Indapamide | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 12 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $66.33 · 3 records | ABBVIE INC. | VRAYLAR, YUPELRI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error